Join
Live feed
·
INSIDERFilingvia Quantisnow
10x Genomics Inc. logo

Director Suliman Shehnaaz sold $464,668 worth of shares (5,723 units at $81.19) as part of a pre-agreed trading plan, decreasing direct ownership by 19% to 23,792 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TXG· 10x Genomics Inc.
Industrials
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TXG (10x Genomics Inc.) and more on Quantisnow.